GSA Capital Partners’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,963
| Closed | -$579K | – | 2075 |
|
|
2025
Q1 | $579K | Buy |
+11,963
| New | +$579K | 0.05% | 694 |
|
|
2024
Q4 | – | Sell |
-25,095
| Closed | -$1.13M | – | 1948 |
|
|
2024
Q3 | $1.13M | Buy |
25,095
+66
| +0.3% | +$2.97K | 0.09% | 393 |
|
|
2024
Q2 | $867K | Sell |
25,029
-30,330
| -55% | -$1.05M | 0.06% | 599 |
|
|
2024
Q1 | $1.6M | Buy |
55,359
+35,571
| +180% | +$1.03M | 0.13% | 199 |
|
|
2023
Q4 | $454K | Buy |
+19,788
| New | +$454K | 0.04% | 859 |
|
|
2023
Q1 | – | Sell |
-55,839
| Closed | -$609K | – | 1849 |
|
|
2022
Q4 | $609K | Buy |
55,839
+43,694
| +360% | +$477K | 0.08% | 480 |
|
|
2022
Q3 | $102K | Buy |
+12,145
| New | +$102K | 0.01% | 1361 |
|
|
2020
Q2 | – | Sell |
-30,928
| Closed | -$218K | – | 1019 |
|
|
2020
Q1 | $218K | Sell |
30,928
-36,258
| -54% | -$256K | 0.05% | 697 |
|
|
2019
Q4 | $474K | Buy |
+67,186
| New | +$474K | 0.06% | 688 |
|